GACP practices

The Future Is Germinating

Pharmaceutical-grade medical cannabis cultivated in Morocco under a regulated national framework.

Cannablanca is one of the first licensed medical cannabis producers in Morocco, combining the country’s longstanding agricultural heritage with international scientific standards. Supported and encouraged by the Moroccan government, we are developing a structured, compliant, and export-oriented model built on outdoor, greenhouse, and indoor cultivation environments.

About Us

A Family-Owned Project
Shaping Morocco’s Medical Cannabis Future

Although Cannablanca is a new project currently in its pilot phase, our team brings strong industry experience from regulated cannabis markets.

Together with our in-house pharmacists, agricultural engineers, laboratory specialists, and quality professionals, we are building a scientifically driven operation aligned with GACP practices and progressing toward GMP compliance.

Cultivation Platform

Our Cultivation Environments

image
Indoor

8 flowering rooms of over 3000 plants each with controlled climate, lighting, CO2 supplementation and standardized quality.

image
Greenhouse

12 climate-assisted greenhouses using natural sunlight combined with controlled ventilation, humidity, and temperature systems for stable, consistent flower development.

image
Outdoor

28 hectares of sun-grown cultivation, working alongside local communities.

Moroccan Advantage

Why Morocco?

Morocco holds decades of agricultural expertise in cannabis cultivation and an ideal climate for consistent production. Today, this heritage is matched with a new, tightly regulated framework for medical cannabis, making the country a competitive and strategically positioned supplier for international markets—especially with direct proximity to Europe,Africa, and global export routes.

Our Mission

Science, Compliance, and Long-Term Partnership

Cannablanca aims to supply pharmaceutical-grade biomass, flower, and future extract-based products while maintaining full traceability, scientific oversight, and transparency. As we grow, we are committed to adapting our production to partner specifications—whether genetics, product category, or quality expectations.